Could this novel drug candidate for bacterial vaginosis replace antibiotics?
Research has pointed scientists to phage lysins as a novel therapeutic approach for the treatment of bacterial vaginosis and suggests phage-based therapies are an ideal alternative to antibiotics.
Please sign in or register for FREE
Sign in to RxNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Future Medicinal Chemistry FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your RxNet account also gives you access to communities on regenerative medicine, real-world evidence and 3D printing in medicine. Find out more>>